---
title: "Modified Huanglian Wendan Decoction for PCOS‑IR: Network Pharmacology Links to AGE‑RAGE Signaling"
id: "pubmed-42816162"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42816162"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42816162/"
doi: "10.1002/cbdv.71737"
published_at: "2026-10-01T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Modified Huanglian Wendan Decoction for PCOS‑IR: Network Pharmacology Links to AGE‑RAGE Signaling
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42816162
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42816162/)
- **DOI:** [10.1002/cbdv.71737](https://doi.org/10.1002%2Fcbdv.71737)
- **Published At:** 2026-10-01T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- This study combined **network pharmacology**, molecular docking, 100‑ns molecular dynamics (MD), chemical profiling, and an in vivo rat model to investigate Modified Huanglian Wendan Decoction (HLWDD) in polycystic ovary syndrome with insulin resistance (PCOS‑IR). - UHPLC‑HRMS/MS identified 997 candidate library assignments from HLWDD, of which 118 were higher‑confidence features; HPLC fingerprinting showed high batch reproducibility. - Network analysis prioritized 136 candidate compounds and found 532 overlapping PCOS‑related targets, with enrichment highlighting **AGE‑RAGE signaling** as a key pathway. - Representative ligand–target complexes remained stable over MD simulations and produced negative MM/PBSA binding free energies, supporting feasible interactions from docking studies. - In a letrozole/high‑fat diet Sprague‑Dawley rat model, HLWDD improved estrous‑cycle recovery and ovarian histology, lowered fasting insulin and HOMA‑IR, reduced reproductive hormones and inflammatory markers. - HLWDD altered ovarian expression of **AGE**, **RAGE**, STAT3, and AKT1; high‑dose HLWDD decreased p‑STAT3/STAT3 and increased p‑AKT/AKT1 versus the model group. - Authors report an association between HLWDD treatment and **AGE‑RAGE/STAT3/AKT**‑related signaling but state that causal pathway mediation was not established. - Results integrate chemical characterization, computational predictions, and phenotypic in vivo effects to provide a biological basis for HLWDD activity in PCOS‑IR, while acknowledging limitations in proving mechanism causality.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42816162/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42816162%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42816162/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42816162/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42816162/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42816162/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42816162/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42816162%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42816162%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42816162/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42816162/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42816162/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42816162/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42816162/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42816162/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42816162/#abstract) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42816162/#references) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42816162/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42816162/#substances) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42816162/#grants) Title & authors Abstract References MeSH terms Substances Grants and funding Chem Biodivers Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chem+Biodivers%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Chem+Biodivers%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) . 2026 Oct;23(10):e71737. doi: 10.1002/cbdv.71737. # Network Pharmacology and In Vivo Evaluation of Modified Huanglian Wendan Decoction in Polycystic Ovary Syndrome With Insulin Resistance: Association With AGE-RAGE-Related Signaling [Xi Chen](https://pubmed.ncbi.nlm.nih.gov/?term=Chen+X&cauthor_id=42816162)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-1 "College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Xing Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+X&cauthor_id=42816162)[#](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-equal-contrib-explanation "Contributed equally")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-3 "Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Xinni Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+X&cauthor_id=42816162)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Dan Chou](https://pubmed.ncbi.nlm.nih.gov/?term=Chou+D&cauthor_id=42816162)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Chenghong Zheng](https://pubmed.ncbi.nlm.nih.gov/?term=Zheng+C&cauthor_id=42816162)[#](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-1 "College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#full-view-affiliation-3 "Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China.") Affiliations Expand ### Affiliations * 1 College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China. * 2 Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China. * 3 Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China. # Contributed equally. * PMID: **42816162** * DOI: [ 10.1002/cbdv.71737 ](https://doi.org/10.1002/cbdv.71737) Item in Clipboard # Network Pharmacology and In Vivo Evaluation of Modified Huanglian Wendan Decoction in Polycystic Ovary Syndrome With Insulin Resistance: Association With AGE-RAGE-Related Signaling Xi Chen et al. Chem Biodivers. 2026 Oct. Show details Display options Display options Format Abstract PubMed PMID Chem Biodivers Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chem+Biodivers%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Chem+Biodivers%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) . 2026 Oct;23(10):e71737. doi: 10.1002/cbdv.71737. ### Authors [Xi Chen](https://pubmed.ncbi.nlm.nih.gov/?term=Chen+X&cauthor_id=42816162)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-1 "College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Xing Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+X&cauthor_id=42816162)[#](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-equal-contrib-explanation "Contributed equally")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-3 "Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Xinni Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+X&cauthor_id=42816162)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Dan Chou](https://pubmed.ncbi.nlm.nih.gov/?term=Chou+D&cauthor_id=42816162)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-2 "Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China."), [Chenghong Zheng](https://pubmed.ncbi.nlm.nih.gov/?term=Zheng+C&cauthor_id=42816162)[#](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-1 "College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42816162/#short-view-affiliation-3 "Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China.") ### Affiliations * 1 College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China. * 2 Department of Gynecology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China. * 3 Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China. # Contributed equally. * PMID: **42816162** * DOI: [ 10.1002/cbdv.71737 ](https://doi.org/10.1002/cbdv.71737) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Modified Huanglian Wendan Decoction (HLWDD) is used for polycystic ovary syndrome with insulin resistance (PCOS-IR), but its biological basis remains incompletely defined. This study integrated network pharmacology, molecular docking, 100-ns molecular dynamics (MD), batch-specific chemical characterization, and in vivo evaluation in a letrozole/high-fat diet rat model. HPLC fingerprinting showed high batch reproducibility, while UHPLC-HRMS/MS identified 997 candidate library assignments, including 118 higher-confidence features. Network analysis identified 136 candidate compounds and 532 overlapping PCOS-related targets, prioritizing AGE-RAGE signaling. Representative docked complexes remained stable during MD and showed negative MM/PBSA binding free energies. In vivo, HLWDD improved estrous-cycle recovery and ovarian morphology, reduced fasting insulin, HOMA-IR, reproductive hormones, and inflammatory markers, and modulated ovarian AGE, RAGE, STAT3, and AKT1 expression. High-dose HLWDD also reduced p-STAT3/STAT3 and increased p-AKT/AKT1 relative to the Model group. These findings support an association between HLWDD treatment and AGE-RAGE/STAT3/AKT-related signaling without establishing causal pathway mediation. **Keywords:** AGE–RAGE signaling; Modified Huanglian Wendan Decoction; insulin resistance; molecular docking; network pharmacology; polycystic ovary syndrome. © 2026 The Author(s). Chemistry & Biodiversity published by Wiley‐VHCA AG. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## References 1. 1. J. Bjekić‐Macut, T. Vukašin, Z. Velija‐Ašimi, et al., “Polycystic Ovary Syndrome: A Contemporary Clinical Approach,” Current Pharmaceutical Design 27, no. 36 (2021): 3812–3820. 2. 1. Y. Chen, Q. Zhang, J. Ma, and Y. Yu, “Mapping Research Trends of Insulin Resistance in Polycystic Ovary Syndrome From 2017 to 2021: A Bibliometric Analysis,” Frontiers in Endocrinology 13 (2022): 963213. 3. 1. M. R. Somagutta, M. Jain, U. Uday, et al., “Novel Antidiabetic Medications in Polycystic Ovary Syndrome,” Discoveries 10, no. 1 (2022): e145. 4. 1. H. J. Teede, C. T. Tay, J. J. E. Laven, et al., “Recommendations From the 2023 International Evidence‐Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome,” European Journal of Endocrinology 189, no. 2 (2023): G43–G64. 5. 1. Y. Li, H. Wu, Y. Guo, et al., “Cangfu Daotan Wan Alleviates Polycystic Ovary Syndrome With Phlegm‐Dampness Syndrome via Disruption of the PKP3/ERCC1/MAPK Axis,” Journal of Ovarian Research 16, no. 1 (2023): 134. Show all 37 references ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Drugs, Chinese Herbal* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drugs%2C+Chinese+Herbal%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drugs%2C+Chinese+Herbal) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Drugs, Chinese Herbal* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drugs%2C+Chinese+Herbal%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drugs%2C+Chinese+Herbal) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Drugs, Chinese Herbal* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drugs%2C+Chinese+Herbal%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drugs%2C+Chinese+Herbal) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Glycation End Products, Advanced* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Glycation+End+Products%2C+Advanced%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Glycation+End+Products%2C+Advanced) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Insulin Resistance* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Insulin+Resistance%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Insulin+Resistance) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Molecular Docking Simulation Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Molecular+Docking+Simulation%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Molecular+Docking+Simulation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Molecular Dynamics Simulation Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Molecular+Dynamics+Simulation%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Molecular+Dynamics+Simulation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Network Pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Network+Pharmacology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Network+Pharmacology) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Polycystic Ovary Syndrome* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Polycystic+Ovary+Syndrome%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Polycystic+Ovary+Syndrome) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Polycystic Ovary Syndrome* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Polycystic+Ovary+Syndrome%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Polycystic+Ovary+Syndrome) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Rats Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Rats%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Rats) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Rats, Sprague-Dawley Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Rats%2C+Sprague-Dawley%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Rats%2C+Sprague-Dawley) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Receptor for Advanced Glycation End Products* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Receptor+for+Advanced+Glycation+End+Products%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Receptor+for+Advanced+Glycation+End+Products) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Signal Transduction / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Signal+Transduction%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Signal+Transduction) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) ## Substances * Drugs, Chinese Herbal Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drugs%2C+Chinese+Herbal%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22Drugs%2C+Chinese+Herbal%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42816162/) * Receptor for Advanced Glycation End Products Actions * [ S
## Related Clinical Research

- [TyG-WHtR and Risk of Incident Thyroid Nodules: Prospective Cohort Analysis](https://medichelpline.com/clinical-feed/pubmed-42897960.md) (DOI: 10.1080/07853890.2026.2748230)
- [Prostate cancer whole-genome profiling in African American men identifies novel drivers](https://medichelpline.com/clinical-feed/plos-one-12-personalized-genomic-landscape-of-prostate-cancer-in-african-american-men.md)
- [Vitamin D Deficiency and Infertility Risk in Women with Polycystic Ovary Syndrome](https://medichelpline.com/clinical-feed/pubmed-42811862.md)
- [Inflammatory Biomarkers and Risk of Postmenopausal ER-Positive Breast Cancer](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-inflammatory-biomarkers-and-risk-of-postmenopausal-oestrogen-receptor-positive.md)
- [Deep learning two-stage framework identifies key genes and pathways in esophageal adenocarcinoma](https://medichelpline.com/clinical-feed/biorxiv-14-novel-two-stage-deep-learning-based-approach-applied-to-gene-expression-data.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.